Licensing requirements play an important role in granting access to Medication-Assisted Treatment (MAT), as they are a key factor in determining the degree to which interested parties can establish accessible treatment options. In order to provide MAT medications, both the providers and the facilities in which they operate must adhere to licensing provisions. These licensing provisions can often represent a barrier to MAT access. While MAT facilities and providers are governed by baseline federal regulations, facilities and providers are often further regulated by statutes and regulations that vary from state to state. Licensing provisions for facilities dictate not only what types of medications can be provided at certain facilities, but also include operational requirements and location-based regulations. Licensing provisions for providers typically govern exactly what type of provider is permitted to prescribe MAT medications through scope of practice laws.
This dataset is cross-sectional and will display key features of licensing provisions related to MAT treatment for facilities and providers across all 50 states and the District of Columbia in effect as of August 1, 2020. This preview link is displaying the coding results for the first batch of 10 states effective through January 1, 2020. These states will be updated prior to publication in August and the team will continue to work on the remaining batches of states.